[Project of invention] [ERBISOL®] [Extra ERBISOL®] [ERBISOL ® UItrapharm] [Publications] [Recomendations] [Doctors' Experience] [Dissertations] [Contact] [News]

Medicus curat, Natura sanat!


Erbisol - inspector and restorer

1996

1. Shipulin V. Изучение еффективности применения препарата Эрбисол® в лечении больных на хронические гепатиты. (61Кб, PDF).*

1999

1. Lopushenko N. Клиническая оценка эффективности препарата Эрбисол® у больных сахарным диабетом. (71Кб, PDF). *

2. Gaystruk N. Профилактика и лечение нарушений фето - плацентарного комплекса при анемии беременных. (89Кб, PDF). RU

2000

1. Klochkov A. Клинико-патогенетическая характеристика и лечение хронического гепатита на фоне туберкулеза легких и хронической алкогольной интоксикации. (292Кб, PDF). UA

2001

1. Konah V. Клиническая оценка эффективности Эрбисола® у больных аутоиммунным тиреоидитом. (71Кб, PDF).*

2. Shestakova K.H. Epidemiological and Clinical-Pathogenetic Grounds for the Organization of Stage Treatment and Rehabilitation of Senile and Aged Patients with Chronic Bronchitis. Manuscript. (196Kb, PDF). UA

2002

1. Litynska T.O. The treatment of patients with alopecia areata with an account for immune status and state of the gastro-intestinal tract. (82Kb, PDF). RU

2. Kozak N.P. Peculiarities of hepatobiliary system pathology in patients with osteoarthrosis : diagnosis, prophylaxis, treatment. (87Кб, PDF). RU *

3. Kuzik F.V. Clinical and Pathogenetic substantiation of treatment of chronic hepatitis combined with the pathology of biliary system. (182Кб, PDF). RU

4. Boreiko L. Особенности функционального состояния щитовидной железы, метаболических и иммунных нарушений у больнных остеоартрозом и их коррекция с помощью Эрбисола® и Рибоксина. (275Kb, PDF). UA

2003

1. Fesenkova V.I. The influence of the Erbisol on functional activity of immunocompetent cells. (105Kb, PDF). RU

2. Kendzerska T.B. The ways of correction of metabolic changes and hemostasis system disturbance in elderly patients with chronic pancreatitis and concomitant ischemic heart disease. (87Кб, PDF). RU

3. Perekhrestenko A.P. The comparative characteristic of the use effectiveness the ultraviolet irradiation and the polarization light in the complex therapy of the psoriasis patients.(159Кб, PDF). UA

4. Krasnova S.P. Set of syndrome of the raised fatigability at the patients with a combined chronic combined pathology hepatobiliar and gastroduodenal zones (clinical-pathogenetic characteristic, treatment, aftertreatment). (192Kb, PDF). UA

5. Sotskaya Ya. Complex treatment and reabilitation of patient with chronic bronchitis on of repeated anginas with use of immunocorrection preparation. (205Kb, PDF). UA

6. Petrunia O. Эффективность антраля и Эрбисола® в комплексной терапии больных простой диабетической ретинопатией. (122Kb, PDF). UA

2004

1. Matvienco Y.A. A functional status eosinophils and basophils of blood of the patient's bronchial asthma and feature of its changes in conditions of application immunocorrectly of preparations. (104Kb, PDF). UA

2. Chybisova I.V. Chronical pathology of hepatobiliary system among pregnant (clinical-pathology characteristics, treatment, obstetricional tactic). (188Кб, PDF). UA

3. Pan'ko O. Обоснование и эффективность применения нового антиоксидантного препарата Эрбисол® при тяжелых ожогах глаз. (125Кб, PDF). UA

4. Kostychenko O.  Противорецидивное лечение больных на полипозный риносинусит. (128Кб, PDF). UA

2005

1. Shapovalov K.A. Clinical-pathogenetic description of the chronic alcoholic hepatitis, connected with chronic uncalculosis cholecystitis, and treatment, in ambulatory-policlinic terms. (206kb, PDF). UA

2. Zubritsky O.S. Peculiarity of development, passing and treatment of duodenal peptic ulcer in military personal. (79kб, PDF). RU

3. Andybura N.Yu. Morphofunctional state of suprarenal gland under lead exposure and during pharmacological correction. (87Кб, PDF). RU

4. Loskutova LI. Immune and metabolic disturbances and their correction in severe and complicated forms of mumps in adults (part 1). (129Kb, PDF). Doctor the disertation. UA

5. Loskutova I.I. Immune and metabolic disturbances and their correction in severe and complicated forms of mumps in adults (part 2). (74b, PDF). Doctor the disertation. UA

6. Bezruk T.A. The clinical-pathogenetic substantiation of erbisol and bee pollen application at the patient with chronic pyelonephritis with accompanying defeats of the gastroduodenal and biliary system. (194Кб, PDF). UA

7. Dzeman N. Коррекция нарушений общеадаптационных реакций организма в комплексном лечении генерализованого пародонтита. (159Кб, PDF). * UA

2006

1. Macidonska I. Peculitiaries of prevalence, diagnostics, clinical course of cosmetic dermatitis. (93Kb, PDF). UA


* Диссертации проводились при содействии с ООО "ЭРБИС".

Upwards pages


Acrobat Reader 5.0+ is necessary to view PDF files


Medicus curat, Natura sanat!


[Project of invention] [ERBISOL®] [Extra ERBISOL®] [ERBISOL ® UItrapharm] [Publications] [Recomendations] [Doctors' Experience] [Dissertations] [Contact] [News]